Physician profile
Patrick S Gavin
NPI 1861620627
$3,537.71
in general payments reported to CMS, 2019-2025
15 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2021: $226 · 2022: $162 · 2023: $108 · 2024: $2,568 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,816 · Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,816.07 |
| Food and Beverage | $1,042.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $2,402.28 | 2024-2025 | Aquabeam System |
| C. R. Bard, INC. & Subsidiaries | $246.23 | 2023-2025 | Bard Urinary Drainage Bag |
| Teleflex LLC | $132.04 | 2021 | |
| Axonics, INC. | $119.53 | 2022 | |
| Coloplast Corp | $113.41 | 2019-2022 | |
| Boston Scientific Corporation | $112.08 | 2019-2021 | |
| Janssen Biotech, INC. | $92.50 | 2019 | |
| Olympus America INC. | $68.64 | 2019-2022 | |
| Urogen Pharma, INC. | $58.24 | 2021-2024 | |
| 180 Medical, INC. | $51.92 | 2023-2024 | |
| Endo Pharmaceuticals INC. | $46.59 | 2021-2023 | Xiaflex |
| Becton, Dickinson and Company | $44.23 | 2024 | Bard Urinary Drainage Bag |
| Ferring Pharmaceuticals INC. | $31.72 | 2024 | Adstiladrin |
| Laborie Medical Technologies Corp. | $14.48 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Travere Therapeutics, INC. | $3.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Gavin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.